Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT07663903 Clinical Landscape Report 2026
11 September 2026
NCT07663903 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Diffuse large B-cell lymphoma recurrent: NCT07808827 Clinical Landscape Report 2026
11 September 2026
NCT07808827 clinical landscape for Diffuse large B-cell lymphoma recurrent: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Tislelizumab in Squamous cell carcinoma of the oral cavity: NCT07812467 Clinical Landscape Report 2026
11 September 2026
NCT07812467 clinical landscape for Squamous cell carcinoma of the oral cavity: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
ARR-002 in Metastatic endometrial cancer: NCT07755436 Clinical Landscape Report 2026
11 September 2026
NCT07755436 clinical landscape for Metastatic endometrial cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BPR001 in Adenocarcinoma of large intestine: NCT07813884 Clinical Landscape Report 2026
11 September 2026
NCT07813884 clinical landscape for Adenocarcinoma of large intestine: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
JSKN033 in Metastatic Carcinoma to the Uterine Cervix: NCT07797153 Clinical Landscape Report 2026
11 September 2026
NCT07797153 clinical landscape for Metastatic Carcinoma to the Uterine Cervix: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Tilrekimig in Eczema: NCT07765888 Clinical Landscape Report 2026
11 September 2026
NCT07765888 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Disitamab Vedotin in HER2 Positive Muscle Invasive Bladder Carcinoma: NCT07783815 Clinical Landscape Report 2026
11 September 2026
NCT07783815 clinical landscape for HER2 Positive Muscle Invasive Bladder Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
BMN-351 in Muscular Dystrophy, Duchenne: NCT07573631 Clinical Landscape Report 2026
11 September 2026
NCT07573631 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
UNC13A program(Trace Neuroscience) in Amyotrophic Lateral Sclerosis: NCT07674667 Clinical Landscape Report 2026
11 September 2026
NCT07674667 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ORM-1153 in Refractory acute myeloid leukemia: NCT07809906 Clinical Landscape Report 2026
11 September 2026
NCT07809906 clinical landscape for Refractory acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Metformin Hydrochloride in Parkinson Disease: NCT07806019 Clinical Landscape Report 2026
11 September 2026
NCT07806019 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.